
Jianfeng Song
Examiner (ID: 5124, Phone: (571)270-1978 , Office: P/1613 )
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1613 |
| Total Applications | 1010 |
| Issued Applications | 492 |
| Pending Applications | 125 |
| Abandoned Applications | 412 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17759841
[patent_doc_number] => 20220233453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => CAPSULE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/545878
[patent_app_country] => US
[patent_app_date] => 2021-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17545878
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/545878 | Capsule formulations | Dec 7, 2021 | Issued |
Array
(
[id] => 18953425
[patent_doc_number] => 20240041752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/264325
[patent_app_country] => US
[patent_app_date] => 2021-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8562
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264325
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/264325 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Dec 5, 2021 | Pending |
Array
(
[id] => 18860130
[patent_doc_number] => 20230414564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => BLUE LIGHT OXIDATION INHIBITOR AND SCREENING METHOD FOR SAME
[patent_app_type] => utility
[patent_app_number] => 18/036618
[patent_app_country] => US
[patent_app_date] => 2021-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18036618
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/036618 | BLUE LIGHT OXIDATION INHIBITOR AND SCREENING METHOD FOR SAME | Nov 28, 2021 | Abandoned |
Array
(
[id] => 18212707
[patent_doc_number] => 20230058971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => EXTENDED RELEASE MICROPARTICLES AND SUSPENSIONS THEREOF FOR MEDICAL THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/530347
[patent_app_country] => US
[patent_app_date] => 2021-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62151
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17530347
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/530347 | EXTENDED RELEASE MICROPARTICLES AND SUSPENSIONS THEREOF FOR MEDICAL THERAPY | Nov 17, 2021 | Abandoned |
Array
(
[id] => 19367355
[patent_doc_number] => 12059415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Stable nimodipine parenteral formulation
[patent_app_type] => utility
[patent_app_number] => 17/523334
[patent_app_country] => US
[patent_app_date] => 2021-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10249
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17523334
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/523334 | Stable nimodipine parenteral formulation | Nov 9, 2021 | Issued |
Array
(
[id] => 19140449
[patent_doc_number] => 20240139234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => PHARMACEUTICAL POLYMER FOR TREATING HYPERKALEMIA AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/260067
[patent_app_country] => US
[patent_app_date] => 2021-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260067
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/260067 | PHARMACEUTICAL POLYMER FOR TREATING HYPERKALEMIA AND PREPARATION METHOD THEREOF | Nov 3, 2021 | Pending |
| 17/516564 | ANTIBACTERIAL AND/OR ANTIVIRAL TREATMENT COMPOSITION FOR OPTICAL COMPONENTS AND METHOD OF APPLICATION | Oct 31, 2021 | Abandoned |
Array
(
[id] => 17412724
[patent_doc_number] => 20220047628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => Synthesis and Antimicrobial Uses of Dinuclear Silver(I) Pyrazolates
[patent_app_type] => utility
[patent_app_number] => 17/513990
[patent_app_country] => US
[patent_app_date] => 2021-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17513990
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/513990 | Synthesis and antimicrobial uses of dinuclear silver(I) pyrazolates | Oct 28, 2021 | Issued |
Array
(
[id] => 18829616
[patent_doc_number] => 20230398140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => OCULAR-TENSION-INCREASING AGENT CAPABLE OF BEING DEPRIVED OF DRUG ACTIVITY BY TEMPERATURE CONTROL
[patent_app_type] => utility
[patent_app_number] => 18/034254
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034254
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/034254 | OCULAR-TENSION-INCREASING AGENT CAPABLE OF BEING DEPRIVED OF DRUG ACTIVITY BY TEMPERATURE CONTROL | Oct 27, 2021 | Pending |
Array
(
[id] => 20120389
[patent_doc_number] => 20250235420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-24
[patent_title] => Phosphate and Arginine Containing Compositions and the Delivery of Such Compositions for Virulence Suppression
[patent_app_type] => utility
[patent_app_number] => 18/702183
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18702183
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/702183 | Phosphate and Arginine Containing Compositions and the Delivery of Such Compositions for Virulence Suppression | Oct 19, 2021 | Pending |
Array
(
[id] => 19608944
[patent_doc_number] => 12157810
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-12-03
[patent_title] => Filled uncured rubber compound for less lethal ammunition and drug-eluting electrospun fiber mat
[patent_app_type] => utility
[patent_app_number] => 17/504706
[patent_app_country] => US
[patent_app_date] => 2021-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6237
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17504706
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/504706 | Filled uncured rubber compound for less lethal ammunition and drug-eluting electrospun fiber mat | Oct 18, 2021 | Issued |
Array
(
[id] => 17426834
[patent_doc_number] => 20220054542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => METHOD OF TREATING EQUINE JOINT INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 17/503520
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503520 | Method of treating equine joint inflammation | Oct 17, 2021 | Issued |
Array
(
[id] => 17398334
[patent_doc_number] => 20220040424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => NASAL CAVITY SAMPLING METHODS AND APPARATUS
[patent_app_type] => utility
[patent_app_number] => 17/503090
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -168
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503090
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503090 | NASAL CAVITY SAMPLING METHODS AND APPARATUS | Oct 14, 2021 | Abandoned |
Array
(
[id] => 17576916
[patent_doc_number] => 20220133771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => Compositions and Methods for Treating or Preventing Gut Permeability-Related Disorders
[patent_app_type] => utility
[patent_app_number] => 17/501142
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501142
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/501142 | Compositions and Methods for Treating or Preventing Gut Permeability-Related Disorders | Oct 13, 2021 | Pending |
Array
(
[id] => 19032383
[patent_doc_number] => 20240082198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => STABILIZED ALKYL NITRITE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/246982
[patent_app_country] => US
[patent_app_date] => 2021-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246982
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246982 | STABILIZED ALKYL NITRITE COMPOSITIONS | Sep 29, 2021 | Pending |
Array
(
[id] => 19150210
[patent_doc_number] => 11975100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Process for preparing pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 17/489296
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 18
[patent_no_of_words] => 4863
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17489296
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/489296 | Process for preparing pharmaceutical compositions | Sep 28, 2021 | Issued |
Array
(
[id] => 17312711
[patent_doc_number] => 20210401759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => PHARMACEUTICAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/470437
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470437 | PHARMACEUTICAL FORMULATIONS | Sep 8, 2021 | Abandoned |
Array
(
[id] => 18238559
[patent_doc_number] => 20230070870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => Covid Nasal Spray
[patent_app_type] => utility
[patent_app_number] => 17/300640
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17300640
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/300640 | Covid Nasal Spray | Sep 8, 2021 | Abandoned |
Array
(
[id] => 18784656
[patent_doc_number] => 20230372249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => PALATABLE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/043743
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043743
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043743 | Palatable formulations | Sep 1, 2021 | Issued |
Array
(
[id] => 18610718
[patent_doc_number] => 20230277448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => CHEWABLE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/043868
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043868
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043868 | CHEWABLE FORMULATIONS | Aug 31, 2021 | Pending |